Organon is an independent global healthcare company focused on improving women's health throughout their lives. Its portfolio includes over 70 medicines and devices in women's health, biosimilars, and established brands, addressing conditions such as reproductive health, cardiovascular disease, and dermatology across more than 140 markets.
AI named Organon from October 2025 to March 2026.
Brand page for organon-com